Login / Signup

Corifollitropin alfa vs recombinant FSH for controlled ovarian stimulation in women aged 35-42 years with a body weight ≥50 kg: a randomized controlled trial.

Lan Ngoc VuongD T PhamH T PhungH N GiangG B HuynhT T L NguyenM T Ho
Published in: Human reproduction open (2017)
19 June 2015.
Keyphrases
  • body weight
  • polycystic ovary syndrome
  • pregnancy outcomes
  • cervical cancer screening
  • cell free
  • breast cancer risk